|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.80 GBX | -1.93% |
|
+7.29% | +15.73% |
| 07-28 | Essentra plc, H1 2026 Earnings Call, Jul 28, 2026 | |
| 07-28 | EARNINGS AND TRADING: Allergy Therapeutics names next executive chair | AN |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 134.12x | 1.27x | 6.26x | 1.29x | 7.93x | 12.3x | 2.04% | 436M | |
| 16.67x | - | 0.82x | - | - | - | - | 15.23B | |
| 23.48x | 2.58x | 1.22x | 2.91x | 12.75x | 16.86x | 1.95% | 10.35B | |
| 333.74x | 17.26x | 6.61x | 70.94x | 235.92x | 315.62x | 0.11% | 9.45B | |
| 19.81x | 1.91x | 0.41x | 2.3x | 10.14x | 11.65x | -.--% | 7.15B | |
| 94.34x | - | 1.52x | 30.75x | 77.68x | 90.45x | 0.24% | 6.52B | |
| 19.05x | 2.93x | 0.76x | 1.76x | 10.34x | 14.01x | 2.09% | 6.46B | |
| 114.04x | 8.27x | 0.42x | 8.91x | 37.74x | 79.28x | 0.32% | 4.3B | |
| 46.37x | 3.49x | 0.49x | 4.84x | 22.42x | 40.66x | 0.74% | 4.24B | |
| 26.5x | 4.75x | 0.91x | - | - | - | - | 2.75B | |
| 27.12x | 3.68x | 1.03x | 4.62x | 20.04x | 22.74x | 1.54% | 2.62B | |
| 19.06x | 1.73x | 1.28x | - | - | - | - | 2.43B | |
| 24.71x | 5.02x | 0.05x | - | - | - | 1.21% | 2.39B | |
| 18.89x | 2.49x | 1.32x | 2.41x | 9x | 13.32x | 2.24% | 2.06B | |
| 21.66x | 3.61x | 0.46x | 2.46x | 12.53x | 16.62x | 1.5% | 1.91B | |
| 32.93x | 1.45x | 0.82x | - | - | - | - | 1.79B | |
| Average | 60.78x | 4.32x | 1.52x | 12.11x | 41.50x | 57.59x | 1.16% | 5.01B | |
| Weighted average by Cap. | 70.71x | 5.60x | 1.57x | 18.20x | 60.59x | 82.12x | 0.97% |
- Stock Market
- Stocks
- ESNT Stock
- Sector Essentra plc
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
